Mark Peterson

4.6k citations

28 papers · 2.6k indexed · 1 hit paper · h-index 19

Impact in

Orthopedics and Sports Medicine top 0.5%
- Bone health and osteoporosis research
- Bone and Joint Diseases
Oncology top 1%
- Bone health and treatments
- Cancer Diagnosis and Treatment

Papers in

Orthopedics and Sports Medicine 7
- Bone health and osteoporosis research 5
Oncology 15
- Bone health and treatments 12
- Cancer Diagnosis and Treatment 3

Co-authors: Pirow Bekker Donna Holloway Matthew M. Riggs Allan Lipton Robert E. Coleman Jean-Jacques Body Michelle Fan Alan Kivitz
Journals: Clinical Cancer Research (3 papers)The Journal of Clinical Pharmacology (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)The AAPS Journal (2 papers)Clinical Pharmacokinetics (2 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Mark Peterson

28 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Denosumab in Postmenopausal Women with Low Bone Mineral Density 2006 · 886 citations

Peers

Countries citing papers authored by Mark Peterson

Since Specialization

Citations

This map shows the geographic impact of Mark Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Peterson more than expected).

Fields of papers citing papers by Mark Peterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Peterson. The network helps show where Mark Peterson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Peterson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Peterson Line = papers co-authored together Mark Peterson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A 3D-Integrated 56 Gb/s NRZ/PAM4 Reconfigurable Segmented Mach-Zehnder Modulator-Based Si-Photonics Transmitter Cheng Li, Kunzhi Yu, Salman A. Alzahrani, Kehan Zhu, N. D. Qi, Marco Fiorentino, Thierry Pinguet, Mark Peterson, Vishal Saxena, Samuel Palermo	2018	27
2	High-Volume Manufacturing Platform for Silicon Photonics Proceedings of the IEEE ·Thierry Pinguet, Mônica Chaves Françozo, Steffen Gloeckner, Michael Mack, G. Masini, Attila Mekis, Shi Yong Wang, Mark Peterson, Subal Sahni, Peter De Dobbelaere	2018	27
3	End-to-End Multi-Core Fibre Transmission Link Enabled by Silicon Photonics Transceiver with Grating Coupler Array Tetsuya Hayashi, Attila Mekis, Tetsuya Nakanishi, Mark Peterson, Subal Sahni, Peng Sun, Nuria Calvet, Victor Chuang, Riley Williams, P. Heidel berger, Thierry Pinguet, Michael Mack, Indonesia Venny, Osamu Shimakawa, S Bozzato, Takashi Sasaki, Peter De Dobbelaere	2017	16
4	Approaches to opto-electronic integration in optical interconnect applications based on Silicon Photonics Subal Sahni, Ali Ayazi, I Nengah Kundera, AN Jing-wen, Peter De Dobbelaere, Steffen Gloeckner, Amany Abdelghany, Ana Isabel Corona-Bravo, Yi Liang, Michael Mack, G. Masini, Attila Mekis, Mark Peterson, Thierry Pinguet, W. Heisig, Francisco Ayala, Peng Sun, M.Günay Van, Lieven Verslegers	2013	3
5	Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours Clinical Pharmacokinetics ·Leonid Gibiansky, Liviawati Sutjandra, Sameer Doshi, Jenny Zheng, Winnie Sohn, Mark Peterson, Graham Jang, Andrew Chow, Juan José Pérez Ruixo	2012	69
6	Multiscale Physiology‐Based Modeling of Mineral Bone Disorder in Patients With Impaired Kidney Function The Journal of Clinical Pharmacology ·Matthew M. Riggs, Mark Peterson, Marc R. Gastonguay	2012	24
7	Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis Clinical Pharmacokinetics ·Liviawati Sutjandra, A. Sukhanov, Sameer Doshi, Mark Ma, Mark Peterson, Graham Jang, Andrew Chow, Juan José Pérez Ruixo	2011	87
8	AAPS Workshop Report: Strategies to Address Therapeutic Protein–Drug Interactions during Clinical Development The AAPS Journal ·Sandhya Girish, Steven W. Martin, Mark Peterson, G Matheus, Hong Zhao, Joseph P. Balthasar, Raymond Evers, Honghui Zhou, Min Zhu, Lewis J. Klunk, Chao Han, Eva Gil Berglund, Shiew‐Mei Huang, Amita Joshi	2011	21
9	Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors The Journal of Clinical Pharmacology ·Peiming Ma, Bingbing Yang, Yow‐Ming Wang, Mark Peterson, Avani Desai, Liviawati Sutjandra, A. Sukhanov, Andrew Chow	2009	69
10	A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling Bone ·Mark Peterson, Matthew M. Riggs	2009	149
11	Percutaneous transhepatic insertion of self-expanding short metal stents for biliary obstruction before resection of pancreatic or duodenal malignancy proves to be safe and effective Surgical Endoscopy ·C Briggs, 尚道村上, 昌範松永, R.J. Peck, Fred Lee, Mark Peterson, Iain Cameron	2009	9
12	“Fit-for-Purpose” Method Validation and Application of a Biomarker (C-terminal Telopeptides of Type 1 Collagen) in Denosumab Clinical Studies The AAPS Journal ·Jin Wang, Jean Lee, Daniel K. Burns, Barbara Schwimmer, Matthew Young, Mark Peterson, Binodh DeSilva	2009	26
13	Systematic Review of Minimally Invasive Pancreatic Resection Journal of Gastrointestinal Surgery ·C Briggs, Christopher D. Mann, 尚道村上, Christopher P. Neal, Mark Peterson, Iain Cameron, David P. Berry	2009	100
14	The Handbook of Cross-Cultural ManagementResearch Peter J. Smith, Mark Peterson, David C. Thomas	2008	100
15	Population PK–PD model for Fc-osteoprotegerin in healthy postmenopausal women Journal of Pharmacokinetics and Pharmacodynamics ·Matthew L. Zierhut, Marc R. Gastonguay, Steven W. Martin, Paolo Vicini, Pirow Bekker, Donna Holloway, Philip T. Leese, Mark Peterson	2008	13
16	Integrated Cellular Bone Homeostasis Model for Denosumab Pharmacodynamics in Multiple Myeloma Patients Journal of Pharmacology and Experimental Therapeutics ·Anshu Marathe, Mark Peterson, Donald E. Mager	2008	60
17	Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy Clinical Cancer Research ·Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa, Zunsheng Bao, Philippe Solal‐Céligny, J.J. Body, Richard de Boer, Rossana Berardi, Pere Gascón, Katia Tonkin, Robert E. Coleman, Alexander Paterson, Guozhi Gao, Maher Benjemaa, Mark Peterson, Susie Jun	2008	118
18	Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases Journal of Clinical Oncology ·Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa, Zunsheng Bao, Philippe Solal‐Céligny, Jean-Jacques Body, Richard de Boer, Rossana Berardi, Pere Gascón, Katia Tonkin, Robert E. Coleman, Alexander Paterson, Mark Peterson, Michelle Fan, Maher Benjemaa, Susie Jun	2007	293
19	Denosumab in Postmenopausal Women With Low Bone Mineral Density Obstetrical & Gynecological Survey ·Michael R. McClung, E. Michael Lewiecki, Stanley Cohen, Michael A. Bolognese, Grattan C. Woodson, Alfred H. Moffett, Munro Peacock, Paul D. Miller, Samuel Lederman, Charles H. Chesnut, Bouc Yves Le, Alan Kivitz, Donna Holloway, Christian Vrængmose Jensen, Mark Peterson, Pirow Bekker	2006	16
20	Denosumab in Postmenopausal Women with Low Bone Mineral Density New England Journal of Medicine ·Michael R. McClung, E. Michael Lewiecki, Stanley Cohen, Michael A. Bolognese, Grattan C. Woodson, Alfred H. Moffett, Munro Peacock, Paul D. Miller, Samuel Lederman, Charles H. Chesnut, Bouc Yves Le, Alan Kivitz, Donna Holloway, Christian Vrængmose Jensen, Mark Peterson, Pirow Bekker Hit paper breakdown →	2006	886

About Mark Peterson

Mark Peterson is a scholar working on Orthopedics and Sports Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Genetics, having authored 28 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bone health and treatments (12 papers), Photonic and Optical Devices (7 papers), Bone Metabolism and Diseases (6 papers), Semiconductor Lasers and Optical Devices (5 papers), Optical Network Technologies (5 papers), Bone health and osteoporosis research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (886 citations), Oncology (1.7k citations), Radiology, Nuclear Medicine and Imaging (427 citations), Rheumatology (236 citations) and Molecular Biology (1.0k citations). Mark Peterson has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Pirow Bekker, Donna Holloway, Matthew M. Riggs, Allan Lipton, Robert E. Coleman, Jean-Jacques Body, Michelle Fan, Alan Kivitz, Paul D. Miller and Michael R. McClung. Their work appears in journals such as Clinical Cancer Research, The Journal of Clinical Pharmacology, CPT Pharmacometrics & Systems Pharmacology, The AAPS Journal and Clinical Pharmacokinetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact